An ultrasound-guided liver biopsy is a routine procedure in which doctors remove a small piece of liver tissue for analysis in a lab. Your doctor might recommend this procedure if they suspect there ...
Novel biomarker tests have met or exceeded the performance of common lab tests for diagnosing nonalcoholic steatohepatitis (NASH, now known as metabolic dysfunction-associated steatohepatitis or MASH) ...
PHILADELPHIA — Percutaneous kidney biopsy is a feasible and safe procedure when testing patients with small kidneys, according to the results of a study presented at ASN Kidney Week. Research into the ...
NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, October is Liver Awareness Month – how a biopsy helps diagnose liver diseases, why fatty liver disease is now on the rise, and how it can ...
Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect and slow the condition early.
hands holding red heart and kidney with stethoscope, world kidney day Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.
Background Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as ...
Semaglutide reduced liver fibrosis and resolved MASH in the ESSENCE trial, offering dual hepatic and metabolic benefits. Read ...
CHICAGO — The current recommended benchmark for when to biopsy the kidney in patients with systemic lupus erythematosus (SLE) is arbitrary and results in missing the lupus nephritis (LN) cases that a ...